These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15894925)

  • 1. Coexpression of CD43 by benign B cells in the terminal ileum.
    Lee PS; Beneck D; Weisberger J; Gorczyca W
    Appl Immunohistochem Mol Morphol; 2005 Jun; 13(2):138-41. PubMed ID: 15894925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of CD43 expression in non-Hodgkin lymphoma. A survey of 742 cases and further characterization of rare CD43+ follicular lymphomas.
    Lai R; Weiss LM; Chang KL; Arber DA
    Am J Clin Pathol; 1999 Apr; 111(4):488-94. PubMed ID: 10191768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of CD20 and CD43 in subclassification of low-grade B-cell lymphoma on paraffin sections.
    Contos MJ; Kornstein MJ; Innes DJ; Ben-Ezra J
    Mod Pathol; 1992 Nov; 5(6):631-3. PubMed ID: 1285443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CD10, CD75 and CD43 in MALT lymphoma and their usefulness in discriminating MALT lymphoma from follicular lymphoma and chronic gastritis.
    Arends JE; Bot FJ; Gisbertz IA; Schouten HC
    Histopathology; 1999 Sep; 35(3):209-15. PubMed ID: 10469212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD43 expression in B cell lymphoma.
    Treasure J; Lane A; Jones DB; Wright DH
    J Clin Pathol; 1992 Nov; 45(11):1018-22. PubMed ID: 1280654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD43 and CD5 antibodies define four normal and neoplastic B-cell subsets: a three-color flow cytometric study.
    Lynch EF; Jones PA; Swerdlow SH
    Cytometry; 1995 Sep; 22(3):223-31. PubMed ID: 8556954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of CD43 and CD200 surface expression improves accuracy of B-cell lymphoma immunophenotyping.
    Hoffmann J; Rother M; Kaiser U; Thrun MC; Wilhelm C; Gruen A; Niebergall U; Meissauer U; Neubauer A; Brendel C
    Cytometry B Clin Cytom; 2020 Nov; 98(6):476-482. PubMed ID: 32716606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell lymphomas with coexpression of CD5 and CD10.
    Dong HY; Gorczyca W; Liu Z; Tsang P; Wu CD; Cohen P; Weisberger J
    Am J Clin Pathol; 2003 Feb; 119(2):218-30. PubMed ID: 12579992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The "CD43 only" phenotype. An aberrant, nonspecific immunophenotype requiring comprehensive analysis for lineage resolution.
    Segal GH; Stoler MH; Tubbs RR
    Am J Clin Pathol; 1992 Jun; 97(6):861-5. PubMed ID: 1595608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous lymphoid hyperplasia and cutaneous marginal zone lymphoma: comparison of morphologic and immunophenotypic features.
    Baldassano MF; Bailey EM; Ferry JA; Harris NL; Duncan LM
    Am J Surg Pathol; 1999 Jan; 23(1):88-96. PubMed ID: 9888708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of T-cell activation by the CD43 molecule whose expression is defective in Wiskott-Aldrich syndrome.
    Park JK; Rosenstein YJ; Remold-O'Donnell E; Bierer BE; Rosen FS; Burakoff SJ
    Nature; 1991 Apr; 350(6320):706-9. PubMed ID: 2023632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of an immunohistochemical panel in paraffin-embedded tissues for the differentiation of B-cell non-Hodgkin's lymphomas of small lymphocytes.
    de Leon ED; Alkan S; Huang JC; Hsi ED
    Mod Pathol; 1998 Nov; 11(11):1046-51. PubMed ID: 9831200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell surface CD43 determination improves diagnostic precision in late B-cell diseases.
    Jung G; Eisenmann JC; Thiébault S; Hénon P
    Br J Haematol; 2003 Feb; 120(3):496-9. PubMed ID: 12580968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukosialin (CD43)-major histocompatibility class I molecule interactions involved in spontaneous T cell conjugate formation.
    Stöckl J; Majdic O; Kohl P; Pickl WF; Menzel JE; Knapp W
    J Exp Med; 1996 Nov; 184(5):1769-79. PubMed ID: 8920865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-specific morphologic differences in extranodal marginal zone B-cell lymphomas.
    Rawal A; Finn WG; Schnitzer B; Valdez R
    Arch Pathol Lab Med; 2007 Nov; 131(11):1673-8. PubMed ID: 17979485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extranodal mantle cell lymphoma mimicking marginal zone cell lymphoma.
    Anagnostopoulos I; Foss HD; Hummel M; Trenn G; Stein H
    Histopathology; 2001 Dec; 39(6):561-5. PubMed ID: 11903572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of beta 1-integrins, H-CAM (CD44) and LECAM-1 in primary gastro-intestinal B-cell lymphomas as compared to the adhesion receptor profile of the gut-associated lymphoid system, tonsil and peripheral lymph node.
    Möller P; Eichelmann A; Mechtersheimer G; Koretz K
    Int J Cancer; 1991 Dec; 49(6):846-55. PubMed ID: 1720425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [CD43 in B-cell chronic lymphocytic leukemia].
    Roliński J; Rupniewska ZM; Dmoszyńska A; Wasik-Szczepanek E; Bojarska-Junak A
    Pol Arch Med Wewn; 1999 Sep; 102(3):753-62. PubMed ID: 10949882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffuse low-grade B-cell lymphomas. Four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features.
    Zukerberg LR; Medeiros LJ; Ferry JA; Harris NL
    Am J Clin Pathol; 1993 Oct; 100(4):373-85. PubMed ID: 8213632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of immunophenotypic abnormalities in paraffin-embedded B-lineage non-Hodgkin's lymphomas.
    Gelb AB; Rouse RV; Dorfman RF; Warnke RA
    Am J Clin Pathol; 1994 Dec; 102(6):825-34. PubMed ID: 7801900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.